An estimated 10,000-12,000 people are living with Lewy body dementia in Ireland, but only a small number of sufferers get an accurate diagnosis ...

Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders ...

Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, conducted a Type C meeting with the U.S. Food ...

It's important to understand that dementia isn't a single condition, but rather a broad term encompassing a range of symptoms ...

A psychologist has provided a deep dive into the crucial stages of dementia, offering guidance on how to recognise them in ...

Detailed price information for Cognition Therapeutics Inc (CGTX-Q) from The Globe and Mail including charting and trades.

Proteins form the building blocks of life, but when they form unusual clumps inside the brain, they raise an alarm that something isn't right.

Researchers from Denmark have uncovered strong evidence that depression often appears years before Parkinson’s disease and ...

Depression is a common comorbidity in Parkinson’s disease (PD) and Lewy body dementia (LBD). However, studies examining the rate of incident depression in the period preceding and following the ...

Health professionals and community members recently gathered at the University of Arkansas for Medical Sciences (UAMS) Donald W. Reynolds Institute on Aging to learn about a wide range of topics and ...

Neflamapimod, an experimental, oral drug targeting neuroinflammation being developed by CervoMed, led to a significant reduction in a key blood biomarker of neurodegeneration, which correlated with a ...